Cytokine-Driven NF-κB Activation in Retinal Cells and Its Impact on the Pathogenesis of Age-Related Macular Degeneration: A Systematic Review

Viqas Shafi,Nabeel Ahmad Khan,Javeria Kazmi,Ifrah Siddiqui

DOI: https://doi.org/10.1101/2024.10.06.24314951

2024-10-07

Abstract:Objective: To investigate the role of cytokine-induced NF-κB activation in retinal pigment epithelium (RPE) and photoreceptor cells, elucidating its contribution to the pathogenesis of Age-related Macular Degeneration (AMD) and identifying potential therapeutic targets. Background: AMD is a leading cause of vision loss in older adults, driven by inflammation, oxidative stress, and immune dysregulation, particularly in RPE and photoreceptor cells. The NF-κB signaling pathway, activated by cytokines such as TNF-α, IL-6, and IL-1β, regulates these pathological processes. Understanding cytokine-induced NF-κB activation may provide insight into AMD progression and facilitate the development of novel therapeutic strategies. Methods: A systematic review of literature from databases including PubMed, MEDLINE, and Google Scholar was conducted to evaluate the involvement of TNF-α, IL-6, IL-1β, IL-8, IFN-γ, IL-17, IL-12, IL-18, IL-33, and IL-25 in activating NF-κB in RPE and photoreceptor cells, contributing to AMD pathogenesis. The search was performed with no date restrictions and followed PRISMA guidelines. Eligible studies were selected based on predefined criteria assessing NF-κB activation mechanisms and its effects on inflammation, oxidative stress, and retinal degeneration. Results: The investigation revealed that cytokines TNF-α, IL-6, IL-1β, IL-8, IFN-γ, IL-17, IL-12, IL-18, IL-33, and IL-25 activate the NF-κB signaling pathway in retinal pigment epithelium (RPE) and photoreceptor cells. This activation triggers the transcription of genes involved in inflammation, oxidative stress, and immune responses. Chronic NF-κB activation leads to persistent inflammation, increased oxidative stress, and immune cell recruitment, contributing to retinal cell dysfunction and degeneration. Additionally, NF-κB-driven upregulation of angiogenic factors such as VEGF promotes neovascularization in wet AMD. These findings highlight the central role of NF-κB in AMD pathogenesis and suggest that targeting this pathway could mitigate inflammatory and oxidative damage, offering potential therapeutic benefits for AMD patients. Conclusion: Cytokine-induced NF-κB activation plays a central role in AMD pathogenesis by promoting chronic inflammation, oxidative stress, and angiogenesis in retinal cells. Targeting NF-κB could present a therapeutic strategy to reduce inflammatory and oxidative damage, preserving retinal function and preventing vision loss in AMD. Further research is required to develop effective NF-κB-targeted interventions.

Allergy and Immunology

What problem does this paper attempt to address?

The problem this paper attempts to address is the exploration of the role of cytokine-induced NF-κB activation in retinal pigment epithelium (RPE) cells and photoreceptor cells, and its impact on the pathological process of age-related macular degeneration (AMD), as well as the identification of potential therapeutic targets.

Specifically, the paper focuses on the following points:
1. **Role of Cytokines**: Investigating how cytokines such as tumor necrosis factor α (TNF-α), interleukin 6 (IL-6), interleukin 1β (IL-1β), interleukin 8 (IL-8), interferon γ (IFN-γ), interleukin 17 (IL-17), interleukin 12 (IL-12), interleukin 18 (IL-18), interleukin 33 (IL-33), and interleukin 25 (IL-25) activate the NF-κB signaling pathway.
2. **Molecular Mechanisms**: Exploring the specific molecular mechanisms by which these cytokines drive NF-κB activation and their effects on cellular processes such as inflammation, oxidative stress, apoptosis, and extracellular matrix remodeling.
3. **Pathological Contribution**: Assessing how these cytokine-induced processes contribute to the onset and progression of AMD.
4. **Therapeutic Strategies**: By elucidating the above mechanisms, the paper aims to identify potential therapeutic targets to reduce inflammation and oxidative damage in AMD patients, thereby protecting retinal function and preventing vision loss.